PEGDA microencapsulated allogeneic islets reverse canine diabetes without immunosuppression

<h4>Background</h4> Protection of islets without systemic immunosuppression has been a long-sought goal in the islet transplant field. We conducted a pilot biocompatibility/safety study in healthy dogs followed by a dose-finding efficacy study in diabetic dogs using polyethylene glycol diacrylate (P...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Stephen Harrington, Francis Karanu, Karthik Ramachandran, S. Janette Williams, Lisa Stehno-Bittel
Format:	Artigo
Jezik:	Inglês
Izdano:	Public Library of Science (PLoS) 2022-01-01
Serija:	PLoS ONE
Online dostop:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132281/?tool=EBI
Oznake:	Označite Brez oznak, prvi označite!